- Home
- VINP vs ARCT Comparison
VINP vs ARCT Comparison
Compare VINP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- ARCT
- Stock Information
- Founded
- VINP 2009
- ARCT 2013
- Country
- VINP Brazil
- ARCT United States
- Employees
- VINP N/A
- ARCT N/A
- Industry
- VINP Investment Managers
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- VINP Finance
- ARCT Health Care
- Exchange
- VINP Nasdaq
- ARCT Nasdaq
- Market Cap
- VINP 641.7M
- ARCT 487.0M
- IPO Year
- VINP 2021
- ARCT N/A
- Fundamental
- Price
- VINP $9.76
- ARCT $16.79
- Analyst Decision
- VINP Strong Buy
- ARCT Strong Buy
- Analyst Count
- VINP 2
- ARCT 7
- Target Price
- VINP $13.50
- ARCT $65.00
- AVG Volume (30 Days)
- VINP 95.1K
- ARCT 400.9K
- Earning Date
- VINP 02-05-2025
- ARCT 03-06-2025
- Dividend Yield
- VINP 5.53%
- ARCT N/A
- EPS Growth
- VINP N/A
- ARCT N/A
- EPS
- VINP 0.60
- ARCT N/A
- Revenue
- VINP $88,217,697.00
- ARCT $160,399,000.00
- Revenue This Year
- VINP $17.23
- ARCT $7.33
- Revenue Next Year
- VINP $51.06
- ARCT $4.71
- P/E Ratio
- VINP $16.31
- ARCT N/A
- Revenue Growth
- VINP 9.03
- ARCT N/A
- 52 Week Low
- VINP $9.01
- ARCT $14.30
- 52 Week High
- VINP $11.85
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- VINP 45.56
- ARCT 46.15
- Support Level
- VINP $9.19
- ARCT $16.07
- Resistance Level
- VINP $10.14
- ARCT $17.95
- Average True Range (ATR)
- VINP 0.24
- ARCT 1.36
- MACD
- VINP -0.00
- ARCT -0.07
- Stochastic Oscillator
- VINP 60.00
- ARCT 14.86
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.